DOCUMENT
Q -- Oncotype Dx Testing Services VISN 18 - Attachment
- Notice Date
- 2/7/2012
- Notice Type
- Attachment
- NAICS
- 621511
— Medical Laboratories
- Contracting Office
- Department of Veterans Affairs;Contracting Section;3601 S. 6th Avenue;Tucson AZ 85723
- ZIP Code
- 85723
- Solicitation Number
- VA25812R0219
- Response Due
- 2/14/2012
- Archive Date
- 3/15/2012
- Point of Contact
- Lillian D Provencio
- E-Mail Address
-
9-4614<br
- Small Business Set-Aside
- N/A
- Description
- The Department of Veterans Affairs, Network Contracting Office (V18 NCO), in support of the VA Southwest Health Care Network (VISN 18.) intends to negotiate a Sole Source Procurement for Oncotype DX Testing Services with Genomic Health Inc., 301 Penobscot Dr. Redwood City, CA 94063-4700. This procurement is being accomplished in accordance with FAR Part 6.302- 1 Only One Responsible Source and No Other Supplies or Services Will Satisfy Agency Requirements. The Oncotype DX assay may be used in newly diagnosed ER+, N- breast cancer patients to predict risk of recurrence. The assay can also be used to identify patients who may be successfully treated with tamoxifen and may not require adjuvant chemotherapy. Tamoxifen-treated patients with an excellent estimated prognosis may be spared adjuvant chemotherapy. The Oncotype DX assay is designed to support individualized treatment planning. The assay provides a quantitative assessment of the likelihood of chemotherapy benefit and distant recurrence, which may increase confidence that the treatment plan is tailored to the individual patient. Oncotype DX assigns a Recurrence Score from 0 to 100 based on the gene expression profile. Higher scores predict a great risk of recurrence and a greater likelihood of benefit from chemotherapy. Lower scores are associated with low risk and minimal chemotherapy benefit. Approximately one third of women with node negative and ER and/or PR positive tumors have been reassigned to a lower risk category and have been spared the expense and adverse effects of chemotherapy. The applicable NAICS for this requirement is 621511and size standard is $13.5 Million. This notice of intent is NOT a request for competitive proposals. A determination not to compete the proposed procurement is based upon responses to this notice is solely within the discretion of the Government. No solicitation document is available and telephone requests will NOT be accepted. However, any firm that believes it can meet the requirements may give written notification to the Contracting Officer. Supporting evidence must be furnished in sufficient detail, to demonstrate the ability to comply with the above requirements by February 14, 2012. Information can be sent to the Contracting Officer (9-90C) via email at Lillian.Provencio @va.gov or ATTN: L. Danielle Provencio, V18 NCO, 3601 S. 6th Avenue, Tucson, AZ 85723. If no responses are received, the V18 NCO will proceed with the sole source procurement to Genomic Health Inc., 301 Penobscot Dr. Redwood City, CA 94063-4700.
- Web Link
-
FBO.gov Permalink
(https://www.fbo.gov/spg/VA/TuVAMC/VASAHCS/VA25812R0219/listing.html)
- Document(s)
- Attachment
- File Name: VA258-12-R-0219 VA258-12-R-0219.docx (https://www.vendorportal.ecms.va.gov/FBODocumentServer/DocumentServer.aspx?DocumentId=294561&FileName=VA258-12-R-0219-000.docx)
- Link: https://www.vendorportal.ecms.va.gov/FBODocumentServer/DocumentServer.aspx?DocumentId=294561&FileName=VA258-12-R-0219-000.docx
- File Name: VA258-12-R-0219 JOFOC FOR FBO.PDF (https://www.vendorportal.ecms.va.gov/FBODocumentServer/DocumentServer.aspx?DocumentId=294562&FileName=VA258-12-R-0219-001.PDF)
- Link: https://www.vendorportal.ecms.va.gov/FBODocumentServer/DocumentServer.aspx?DocumentId=294562&FileName=VA258-12-R-0219-001.PDF
- Note: If links are broken, refer to Point of Contact above or contact the FBO Help Desk at 877-472-3779.
- File Name: VA258-12-R-0219 VA258-12-R-0219.docx (https://www.vendorportal.ecms.va.gov/FBODocumentServer/DocumentServer.aspx?DocumentId=294561&FileName=VA258-12-R-0219-000.docx)
- Record
- SN02669373-W 20120209/120207235320-5429da6423ed6b203d4af0b5d475fdf1 (fbodaily.com)
- Source
-
FedBizOpps Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's FBO Daily Index Page |